We are live on ! Find out more
PFCS

Pale Fire Capital SE Portfolio holdings

AUM $1.14B
1-Year Est. Return 42.87%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+42.87%
3 Year Est. Return
+176.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$638M
AUM Growth
-$249M
Cap. Flow
-$253M
Cap. Flow %
-39.63%
Top 10 Hldgs %
91.27%
Holding
68
New
21
Increased
18
Reduced
13
Closed
14

Top Buys

Rank Stock Value
1
IAUX
i-80 Gold Corp
IAUX
+$9.95M
2
TDOC icon
Teladoc Health
TDOC
+$8.11M
3
CIM
Chimera Investment
CIM
+$5.08M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$3.63M
5
OCUL icon
Ocular Therapeutix
OCUL
+$3.61M

Top Sells

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$154M
2
NMM icon
Navios Maritime Partners
NMM
+$26.7M
3
DOLE icon
Dole
DOLE
+$24.6M
4
STNG icon
Scorpio Tankers
STNG
+$22.9M
5
T icon
AT&T
T
+$17.5M

Sector Composition

Rank Sector Weight
1 Communication Services 51.91%
2 Consumer Staples 16.73%
3 Materials 12.6%
4 Energy 9.01%
5 Healthcare 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XFOR icon
26
X4 Pharmaceuticals
XFOR
$375M
$1.07M 0.17%
53,426
+47,525
+805% +$992K
RAPT
27
DELISTED
RAPT Therapeutics
RAPT
$1.03M 0.16%
63,841
+61,832
+3,078% +$1.25M
MITT
28
TPG Mortgage Investment Trust
MITT
$222M
$1M 0.16%
+133,271
New +$967K
INZY
29
DELISTED
Inozyme Pharma
INZY
$986K 0.15%
188,537
+149,636
+385% +$777K
RNW icon
30
ReNew
RNW
$2.27B
$373K 0.06%
59,289
+41,668
+236% +$247K
IOVA icon
31
Iovance Biotherapeutics
IOVA
$1.82B
$351K 0.06%
37,375
+22,675
+154% +$215K
IRON icon
32
Disc Medicine
IRON
$2.94B
$325K 0.05%
+6,609
New +$310K
IMTX icon
33
Immatics
IMTX
$1.18B
$279K 0.04%
24,462
+12,938
+112% +$153K
BHVN icon
34
Biohaven
BHVN
$2.03B
$275K 0.04%
+5,496
New +$214K
CELC icon
35
Celcuity
CELC
$4.21B
$260K 0.04%
17,458
+5,805
+50% +$95.7K
CMCT
36
Creative Media & Community Trust
CMCT
$10.3M
$239K 0.04%
19
+1
+6% +$50.4K
CMRX
37
DELISTED
Chimerix, Inc.
CMRX
$237K 0.04%
254,963
+88,756
+53% +$79.2K
BDTX icon
38
Black Diamond Therapeutics
BDTX
$96.8M
$230K 0.04%
52,985
+13,985
+36% +$76.1K
VERV
39
DELISTED
Verve Therapeutics
VERV
$221K 0.03%
+45,600
New +$265K
TCRX icon
40
TScan Therapeutics
TCRX
$48.6M
$218K 0.03%
43,723
+22,150
+103% +$134K
LRMR icon
41
Larimar Therapeutics
LRMR
$397M
$212K 0.03%
32,309
+18,017
+126% +$145K
EWTX icon
42
Edgewise Therapeutics
EWTX
$4.13B
$205K 0.03%
+7,686
New +$153K
ACHV icon
43
Achieve Life Sciences
ACHV
$659M
$157K 0.02%
+33,119
New +$151K
AQST icon
44
Aquestive Therapeutics
AQST
$463M
$120K 0.02%
+24,000
New +$93.4K
RZLT icon
45
Rezolute
RZLT
$454M
$118K 0.02%
+24,289
New +$112K
SYRS
46
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$106K 0.02%
+49,211
New +$177K
CMPX icon
47
Compass Therapeutics
CMPX
$344M
$56.1K 0.01%
30,507
-52,270
-63% -$65.1K
CLRB icon
48
Cellectar Biosciences
CLRB
$20.5M
$53.6K 0.01%
+834
New +$55K
ODV
49
DELISTED
Osisko Development Corp
ODV
$51.7K 0.01%
24,291
-10,769
-31% -$22.5K
BWEN icon
50
Broadwind
BWEN
$93.6M
$50K 0.01%
+22,026
New +$58K
1
2
3

Similar funds

WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
SAM
SP Asset Management Cupertino, California $1.13B AUM 12.57% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
BBP
Banco BTG Pactual Rio De Janeiro, Brazil $1.14B AUM 41.39% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return

Pale Fire Capital SE's Q3 2024 Portfolio in Review

As of Q3 2024, Pale Fire Capital SE held 68 positions worth $638M, down 28% from $887M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Pale Fire Capital SE withdrew a net $253M in Q3 2024, closing 14 positions and reducing 13 holdings. Its most notable exit was Noble Corp, an estimated $8.31M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 52% of assets, up from 42% a quarter earlier, followed by Consumer Staples and Materials.

Against the trend, Pale Fire Capital SE opened a new position in Chimera Investment worth $5.37M.

  • Pale Fire Capital SE's largest Q3 2024 buy was Chimera Investment: 339,473 shares worth $5.37M.
  • Pale Fire Capital SE added most to i-80 Gold Corp in Q3 2024, an estimated $9.95M increase.
  • Pale Fire Capital SE's biggest Q3 2024 reduction was Shell, cutting an estimated $154M.
  • Pale Fire Capital SE fully exited Noble Corp in Q3 2024, selling an estimated $8.31M.
  • Pale Fire Capital SE's ten largest holdings make up 91% of its $638M portfolio in Q3 2024.
  • Pale Fire Capital SE opened 21 new positions and closed 14 in Q3 2024.
  • Pale Fire Capital SE's portfolio value fell 28% quarter-over-quarter to $638M.

Based on Pale Fire Capital SE's 13F filing for Q3 2024, filed 12 Nov 2024.